Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.
Journal: Molecular cancer therapeutics
Published: August 22, 2025
Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples.
Journal: Clinical epigenetics
Published: March 28, 2024
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo.
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo.
Journal: Nature communications
Published: October 03, 2022
Showing 1-3 of 3
Last Updated: 09/26/2026